A CAR recognizing the EBV latent membrane protein 1 (LMP1) exhibited specific cytolytic activity against LMP1-positive nasopharyngeal tumor line and reduced tumor growth in a xenograft model23. The gene discussed is PDLIM7; the disease is nasopharyngeal neoplasm.